| abstract |
Crystalline forms of the base as well as solvates and hydrates in these salt forms, a process for their preparation, their usefulness in therapy and the pharmaceutical compositions containing them, are also claimed and described in the present application. Claim 1: Salts of compound 937 with the following formula characterized in that they are selected from L-tartrate, succinate, phosphate, mesylate, maleate, L-malate, hydrochloride, fumarate (half mole of counterion), fumarate, citrate (half mole of counterion ), benzenesulfonate and L-aspartate (half mole of counterion), and their crystalline forms, solvates and hydrates. |